Mellon Christophe, Aspiotis Reneé, Black Cameron W, Bayly Christopher I, Grimm Erich L, Giroux André, Han Yongxin, Isabel Elise, McKay Daniel J, Nicholson Donald W, Rasper Dita M, Roy Sophie, Tam John, Thornberry Nancy A, Vaillancourt John P, Xanthoudakis Steven, Zamboni Robert
Merck Frosst Centre for Therapeutic Research, Merck Frosst Canada & Co., P.O. Box 1005, Pointe-Claire-Dorval, Que., Canada H9R 4P8.
Bioorg Med Chem Lett. 2005 Sep 1;15(17):3886-90. doi: 10.1016/j.bmcl.2005.05.116.
Caspase 3 is a cysteinyl protease that mediates apoptotic cell death. Its inhibition may have an important impact in the treatment of several degenerative diseases. The P1 aspartic acid residue is a required element of recognition for this enzyme that was maintained constant along with the adjacent natural valine as the P2 group. The thiobenzylmethylketone warhead on the aspartate was conveniently handled through solid-phase synthesis allowing modification in the P3 region that eventually led to simpler derivatives with increased potency against caspase 3. The key to such an effect is the introduction of hydroxyl group alpha to the P3 carbonyl.
半胱天冬酶3是一种介导细胞凋亡性死亡的半胱氨酸蛋白酶。其抑制作用可能对几种退行性疾病的治疗产生重要影响。P1天冬氨酸残基是该酶识别所需的一个元素,它与相邻的天然缬氨酸作为P2基团一起保持不变。天冬氨酸上的硫代苄基甲基酮弹头通过固相合成便于处理,从而允许在P3区域进行修饰,最终得到对半胱天冬酶3具有更高效力的更简单衍生物。这种效应的关键在于在P3羰基的α位引入羟基。